{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:51:15Z","timestamp":1772632275040,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371835, 82203510, 82372822"],"award-info":[{"award-number":["82371835, 82203510, 82372822"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen causing severe hemorrhagic disease with high mortality. The viral glycoprotein Gc mediates membrane fusion and represents a key target of CD8\u207a T-cell responses. However, systematic identification and comprehensive evaluation of pan-MHC-I-restricted Gc epitopes remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An integrated immunoinformatics workflow incorporating five prediction algorithms (IEDB, NetMHCpan4.1, SMMPMBEC, SYFPEITHI, and Rankpep) was applied to identify high-affinity 9-mer epitopes from the CCHFV Gc protein restricted by human HLA-I and murine H2 alleles. Immunogenicity, conservation, toxicity, and allergenicity were assessed using established computational tools. Peptide\u2013MHC interactions were further examined by molecular docking and molecular dynamics simulations. Selected epitopes were experimentally validated by ELISpot assays in BALB\/c and SJL mice immunized with a Gc-based DNA vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety-four human HLA-I and thirty-seven murine H2-restricted dominant epitopes were predicted. Among these, 21 epitopes exhibited high binding affinity, favorable immunogenicity, and broad conservation across viral strains. Most candidates showed low predicted toxicity and allergenicity. Structural analyses supported stable peptide\u2013MHC interactions. ELISpot assays confirmed that several epitopes, including APFILLILF and FVKWKVEYI, elicited significant IL-2 responses, indicating functional T-cell activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a systematic framework for identifying conserved and immunogenic pan-MHC-I-restricted epitopes within the CCHFV Gc protein. The validated candidates may support the rational design of multi-epitope vaccines and contribute to understanding cellular immune responses against CCHFV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1693892","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:58:12Z","timestamp":1772607492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal"],"prefix":"10.3389","volume":"17","author":[{"given":"Dongbo","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Microbiology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]},{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]},{"name":"Department of Rehabilitation Medicine, Tangdu Hospital, Air-Force Medical University (The Fourth Military Medical University)","place":["Xi\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]},{"name":"Beijing Institute of Radiation Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haobo","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenchi","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilu","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubo","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihe","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enqi","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjie","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baozeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Yingtan Detachment, Jiangxi Corps, Chinese People\u2019s Armed Police","place":["Yingtan, China"]},{"name":"Changzheng Hospital, Naval Medical University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Immunology, The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linfeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University)","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean-congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41541-023-00663-5","article-title":"Gp38 as a vaccine target for crimean-congo hemorrhagic fever virus","volume":"8","author":"Scher","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0009973","DOI":"10.1371\/journal.pntd.0009973","article-title":"Immune responses in multiple hosts to nucleocapsid protein (Np) of crimean-congo hemorrhagic fever virus (Cchfv)","volume":"15","author":"Karaaslan","year":"2021","journal-title":"PloS Negl Trop Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16189.1","article-title":"Recent advances in understanding crimean-congo hemorrhagic fever virus","volume":"7","author":"Hawman","year":"2018","journal-title":"F1000Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3201\/eid2409.171427","article-title":"World health organization methodology to prioritize emerging infectious diseases in need of research and development","volume":"24","author":"Mehand","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl6502","article-title":"Structural basis of synergistic neutralization of crimean-congo hemorrhagic fever virus by human antibodies","volume":"375","author":"Mishra","year":"2022","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2012.1061","article-title":"Pathogenesis of crimean-congo hemorrhagic fever","volume":"13","author":"Akinci","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0204264","DOI":"10.1371\/journal.pone.0204264","article-title":"Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from crimean-congo hemorrhagic fever virus","volume":"13","author":"Moming","year":"2018","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00871-9","article-title":"Crimean-congo haemorrhagic fever virus","volume":"21","author":"Hawman","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104212","article-title":"Cd8+ T cells: the past and future of immune regulation","volume":"357","author":"Lees","year":"2020","journal-title":"Cell Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110725","article-title":"Immunoinformatics-based multi-epitope vaccine design for the re-emerging monkeypox virus","volume":"123","author":"Farzan","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.120139","article-title":"T-cell epitope vaccine design by immunoinformatics","volume":"3","author":"Patronov","year":"2013","journal-title":"Open Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.76071","article-title":"Multi-omics insights into host-viral response and pathogenesis in crimean-congo hemorrhagic fever viruses for novel therapeutic target","volume":"11","author":"Neogi","year":"2022","journal-title":"Elife"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02076-16","article-title":"Immunization with DNA plasmids coding for crimean-congo hemorrhagic fever virus capsid and envelope proteins and\/or virus-like particles induces protection and survival in challenged mice","volume":"91","author":"Hinkula","year":"2017","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1078045","article-title":"A Crimean-Congo Hemorrhagic Fever (Cchf) Viral Vaccine Expressing Nucleoprotein Is Immunogenic but Fails to Confer Protection against Lethal Disease","volume":"12","author":"Dowall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0003579","DOI":"10.1371\/journal.pntd.0003579","article-title":"Immunization of knock-out alpha\/beta interferon receptor mice against high lethal dose of crimean-congo hemorrhagic fever virus with a cell culture based vaccine","volume":"9","author":"Canakoglu","year":"2015","journal-title":"PloS Negl Trop Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05352-11","article-title":"Mice orally immunized with a transgenic plant expressing the glycoprotein of crimean-congo hemorrhagic fever virus","volume":"18","author":"Ghiasi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.084","article-title":"Enhancing DNA immunization by targeting asfv antigens to sla-ii bearing cells","volume":"29","author":"Argilaguet","year":"2011","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1121163","article-title":"Construction and evaluation of DNA vaccine encoding crimean congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with lamp1","volume":"13","author":"Hu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00442","article-title":"Better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools","volume":"11","author":"De Groot","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0389-5_6","article-title":"Immunoinformatics and epitope prediction","volume":"2131","author":"Ramana","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105244","article-title":"Immunobiology of crimean-congo hemorrhagic fever","volume":"199","author":"Rodriguez","year":"2022","journal-title":"Antiviral Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0302224","DOI":"10.1371\/journal.pone.0302224","article-title":"Genetic background of adaptation of crimean-congo haemorrhagic fever virus to the different tick hosts","volume":"19","author":"SC","year":"2024","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/v14030544","article-title":"Mapping of antibody epitopes on the crimean-congo hemorrhagic fever virus nucleoprotein","volume":"14","author":"Lombe","year":"2022","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101693","article-title":"Computational formulation and immune dynamics of a multi-peptide vaccine candidate against crimean-congo hemorrhagic fever virus","volume":"55","author":"Khan","year":"2021","journal-title":"Mol Cell Probes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.2124","article-title":"Naive precursor frequencies and mhc binding rather than the degree of epitope diversity shape cd8+ T cell immunodominance","volume":"181","author":"Kotturi","year":"2008","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<907::AID-IMMU907>3.0.CO;2-4","article-title":"Calnexin expression does not enhance the generation of mhc class I-peptide complexes","volume":"28","author":"Prasad","year":"1998","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.06.044","article-title":"A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1n1 pig challenge model","volume":"37","author":"Hewitt","year":"2019","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(94)90155-4","article-title":"Efficient mhc class I-peptide binding is required but does not ensure mhc class I-restricted immunogenicity","volume":"31","author":"Feltkamp","year":"1994","journal-title":"Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1092","article-title":"The immune epitope database (Iedb): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molp.2020.06.009","article-title":"Tbtools: an integrative toolkit developed for interactive analyses of big biological data","volume":"13","author":"Chen","year":"2020","journal-title":"Mol Plant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","article-title":"Toxinpred2: an improved method for predicting toxicity of proteins","volume":"23","author":"Sharma","year":"2022","journal-title":"Brief Bioinform"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa294","article-title":"Algpred 2.0: an improved method for predicting allergenic proteins and mapping of ige epitopes","volume":"22","author":"Sharma","year":"2021","journal-title":"Brief Bioinform"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114142","article-title":"Toward rational vaccine engineering","volume":"183","author":"Vishweshwaraiah","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.12.001","article-title":"Recombinant DNA vaccine of hantavirus gn and lamp1 induced long-term immune protection in mice","volume":"138","author":"Jiang","year":"2017","journal-title":"Antiviral Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101620","article-title":"In silico analyses, experimental verification and application in DNA vaccines of ebolavirus gp-derived pan-mhc-ii-restricted epitopes","volume":"11","author":"Zhang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/1098-2272(200101)20:1<87::AID-GEPI8>3.0.CO;2-R","article-title":"Ramifications of hla class I polymorphism and population genetics for vaccine development","volume":"20","author":"Dawson","year":"2001","journal-title":"Genet Epidemiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010061","article-title":"An immunoinformatics approach to design a potent multi-epitope vaccine against asia-1 genotype of crimean-congo haemorrhagic fever virus using the structural glycoproteins as a target","volume":"11","author":"Shah","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214876","article-title":"Corrigendum: integration: gospel for immune bioinformatician on epitope-based therapy","volume":"14","author":"Sun","year":"2023","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00752-06","article-title":"Crimean-congo hemorrhagic fever virus genomics and global diversity","volume":"80","author":"Deyde","year":"2006","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1038\/s41467-023-43206-1","article-title":"Interactome profiling of crimean-congo hemorrhagic fever virus glycoproteins","volume":"14","author":"Dai","year":"2023","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.12.015","article-title":"Antibody responses and viral load in patients with crimean-congo hemorrhagic fever: A comprehensive analysis during the early stages of the infection","volume":"79","author":"Ergunay","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant lassa-rabies vaccine are critical for protection against lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1693892\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:58:14Z","timestamp":1772607494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1693892\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2026.1693892"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1693892","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1693892"}}